|

AUCD Community Inclusion

AUCD’s Community Inclusion Team supports the University Centers for Excellence in Developmental Disabilities (UCEDD) Network in partnership with the Administration for Community Living.

Learn More
|

AUCD Maternal and Child Health Engagement

AUCD’s Maternal and Child Health Engagement supports the Autism CARES Programs, including LEND and DBP Programs.

Learn More
|

AUCD Public Health

AUCD’s Public Health Team works to create health promotion and public health efforts that include people with disabilities.

Learn More
|

AUCD Emerging Leaders Community

AUCD Emerging Leaders are a part of a community that includes trainees, early career professionals, self-advocates, and family members from AUCD member Centers and Programs.

Learn More

Donate

Project

VX14-661-108

Center:

AZ-UA PPC

Fiscal Year:

2017

Contact Information:

Lisa Rascon
[email protected]
520-626-1567

Project Description:

A Phase 3, randomized, double-blind, placebo-controlled, crossover study to evaluate eht efficacy and safety of Ivacaftor and VX-661 in combination with Ivacaftor in subjects aged 12 years and older with cystic fibrosis, heterozygous for the F508del-CFTR mutation, and a second Allele with CFTR mutation predicted to have residual function.

Keyword(s):

Core Function(s):

Performing Research or Evaluation

Area of Emphasis

Health-Related Activities

Target Audience:

Professionals and Para-Professionals

Unserved or Under-served Populations:

Racial or Ethnic Minorities, Disadvantaged Circumstances, Limited English, Geographic Areas

Primary Target Audience Geographic Descriptor:

National

Funding Source: